HeartBeam ECG Registry: See How Heartbeat Patterns Look Across People
Official title: Collection of ECG Recordings Using the HeartBeam 3-Lead ECG Recorder
Run by HeartBeam, Inc. · NCT07501299 · Data updated 2026-11-12
This registry tests HeartBeam ECG recordings in real-world patients to build a de-identified database for research.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 600 (estimated) |
| Sponsor | HeartBeam, Inc. Industry-sponsored |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Status | Recruiting |
| Started | March 30, 2026 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | July 20, 2026 |
| Trial ID | NCT07501299 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults undergoing ECG as part of standard care who can provide informed consent.
✕Probably not a fit
Patients who choose not to participate or whose data cannot be de-identified may not benefit directly.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry collects ECG data captured with the HeartBeam system from patients with various heart rhythm conditions. It includes measurements from normal and abnormal rhythms, conduction issues, and rate abnormalities, with demographic and clinical context. The goal is to create a diverse, de-identified ECG database to support future research and regulatory reviews of the device’s performance. Data will be analyzed to understand how the HeartBeam system performs across different rhythm types and patient subgroups. Enrollment is open to patients undergoing ECG as part of standard care at participating sites.
Why it matters
Potential benefit: If successful, the registry could help improve understanding of HeartBeam performance across diverse patients and conditions.
How similar studies have gone: Other ECG registries and device-recording studies have used similar approaches to build usable ECG datasets.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Undergoing ECG as part of standard of care. 2. Able and willing to provide written informed consent. Exclusion Criteria: 1. Open chest wounds or surgery to the chest or abdomen within 30 days. 2. Inability to complete ECG acquisition with either HeartBeam device or standard 12-L ECG. 3. Unstable condition where registry participation may interfere with care.
Where it's running
-
Allegheny Health Network
Pittsburgh, Pennsylvania, United States Recruiting
Study contacts
- Study coordinator: Pooja Chatterjee
- Email: pchatterjee@heartbeam.com
- Phone: 408-899-4443
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Observing patients with BIOTRONIK Implantable Cardiac Monitors
This study looks at how well the BIOMONITOR III and similar heart monitors work and keep patients safe over time.
-
Sedation with dexmedetomidine, propofol, or both during cataract surgery
This project will test whether dexmedetomidine, propofol, or their combination (each given with fentanyl) provides the best sedation, safety, and surgeon satisfaction for adults having cataract surgery.
-
RHYthm and Myocardial Function Relationship in Heart Disease
This study tests how heart rhythm patterns relate to heart muscle function in adults with arrhythmias or cardiomyopathy.
-
BIOTRONIK CSP Lead Registry for Left Bundle Branch Area Pacing
This registry tests BIOTRONIK’s CSP-based pacing lead in patients needing a pacemaker or CRT, to see how it performs in real-life use.
-
Using the VERAFEYE imaging and navigation system to guide catheter ablation for atrial arrhythmias
This study will try the VERAFEYE imaging and guidance system during catheter ablation in adults with atrial flutter or atrial fibrillation to see if it integrates well with standard procedures.
-
Anatomical navigation to guide catheter ablation for atrial fibrillation and flutter
This trial will test whether the VERAFEYE Anatomical Guidance System helps doctors guide catheter ablation in adults with atrial fibrillation or atrial flutter.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.